Terms: = Breast cancer AND RUNX1, PEBP2A2, 861, ENSG00000159216, Q01196, AML1, CBFA2, AMLCR1
455 results:
1. The use of longitudinal CT-based radiomics and clinicopathological features predicts the pathological complete response of metastasized axillary lymph nodes in breast cancer.
Wang J; Tian C; Zheng BJ; Zhang J; Jiao DC; Qu JR; Liu ZZ
BMC Cancer; 2024 May; 24(1):549. PubMed ID: 38693523
[TBL] [Abstract] [Full Text] [Related]
2. Racial/ethnic differences in 21-gene recurrence score and survival among patients with estrogen receptor-positive breast cancer.
Gill J; Yendamuri K; Chatterjee U; Yao S; Oladeru OT; Singh AK; Ma SJ
BMC Cancer; 2024 Apr; 24(1):461. PubMed ID: 38614979
[TBL] [Abstract] [Full Text] [Related]
3. Predicting pathological complete response to neoadjuvant chemotherapy in breast cancer patients: use of MRI radiomics data from three regions with multiple machine learning algorithms.
Zheng G; Peng J; Shu Z; Jin H; Han L; Yuan Z; Qin X; Hou J; He X; Gong X
J Cancer Res Clin Oncol; 2024 Mar; 150(3):147. PubMed ID: 38512406
[TBL] [Abstract] [Full Text] [Related]
4. Construction and validation of nomogram for the cancer-specific mortality for HER2-positive breast cancer patients.
Wu N
Medicine (Baltimore); 2024 Mar; 103(11):e37330. PubMed ID: 38489717
[TBL] [Abstract] [Full Text] [Related]
5. Identifying prognostic biomarkers for palbociclib add-on therapy in fulvestrant-resistant breast cancer using cell-free DNA sequencing.
Takeshita T; Iwamoto T; Niikura N; Watanabe K; Kikawa Y; Kobayashi K; Iwakuma N; Okamura T; Tada H; Ozaki S; Okuno T; Toh U; Yamamoto Y; Tsuneizumi M; Ishiguro H; Masuda N; Saji S
ESMO Open; 2024 Apr; 9(4):102385. PubMed ID: 38387111
[TBL] [Abstract] [Full Text] [Related]
6. Concurrent Use of Statins in Patients Undergoing Curative Intent Treatment for Triple Negative breast cancer: A Systematic Review and Meta-Analysis.
McKechnie T; Brown Z; Lovrics O; Yang S; Kazi T; Eskicioglu C; Parvez E
Clin Breast Cancer; 2024 Apr; 24(3):e103-e115. PubMed ID: 38296737
[TBL] [Abstract] [Full Text] [Related]
7. Sonography-based multimodal information platform for identifying the surgical pathology of ductal carcinoma in situ.
Wu H; Jiang Y; Tian H; Ye X; Cui C; Shi S; Chen M; Ding Z; Li S; Huang Z; Luo Y; Peng Q; Xu J; Dong F
Comput Methods Programs Biomed; 2024 Mar; 245():108039. PubMed ID: 38266556
[TBL] [Abstract] [Full Text] [Related]
8. Integrating single-cell and bulk transcriptomic analyses to develop a cancer-associated fibroblast-derived biomarker for predicting prognosis and therapeutic response in breast cancer.
Li C; Yang L; Zhang Y; Hou Q; Wang S; Lu S; Tao Y; Hu W; Zhao L
Front Immunol; 2023; 14():1307588. PubMed ID: 38235137
[TBL] [Abstract] [Full Text] [Related]
9. Increased runx1 mutations in breast cancer disease progression.
Ariffin NS
Pathol Res Pract; 2024 Feb; 254():155076. PubMed ID: 38219493
[TBL] [Abstract] [Full Text] [Related]
10.
Li J; Yin Y; Huang H; Li M; Li H; Zhang M; Jiang C; Yang R
Epigenomics; 2023 Dec; 15(23):1257-1272. PubMed ID: 38126720
[No Abstract] [Full Text] [Related]
11. Incidence and risk factors of hypothyroidism after treatment for early breast cancer: a population-based cohort study.
Digkas E; Smith DR; Wennstig AK; Matikas A; Tegnelius E; Valachis A
Breast Cancer Res Treat; 2024 Feb; 204(1):79-87. PubMed ID: 38057688
[TBL] [Abstract] [Full Text] [Related]
12. The effects of breast density on the benefits of mammograms with adjunctive ultrasonography in breast screening.
Nakamura A; Ohnuki K; Takahashi H; Usami S; Ishida Y; Shibata S; Umemura A; Takikawa Y; Kano A
Breast Cancer; 2024 Mar; 31(2):228-233. PubMed ID: 38012337
[TBL] [Abstract] [Full Text] [Related]
13. Physiological Uptake Characteristics of breast on
Zhang Y; Zhou Y; Tian R; Su M
Mol Imaging Biol; 2023 Dec; 25(6):1045-1053. PubMed ID: 37945972
[TBL] [Abstract] [Full Text] [Related]
14. The interaction of diet, alcohol, genetic predisposition, and the risk of breast cancer: a cohort study from the UK Biobank.
Zhu P; Zhang Y; Chen Q; Qiu W; Chen M; Xue L; Lin M; Yang H
Eur J Nutr; 2024 Mar; 63(2):343-356. PubMed ID: 37914956
[TBL] [Abstract] [Full Text] [Related]
15. Construction of a comprehensive predictive model for axillary lymph node metastasis in breast cancer: a retrospective study.
Li Y; Han D; Shen C; Duan X
BMC Cancer; 2023 Oct; 23(1):1028. PubMed ID: 37875818
[TBL] [Abstract] [Full Text] [Related]
16. Scutellarin suppresses the metastasis of triple-negative breast cancer via targeting TNFα/TNFR2-runx1-triggered G-CSF expression in endothelial cells.
Mei X; Ouyang H; Zhang H; Jia W; Lu B; Zhang J; Ji L
Biochem Pharmacol; 2023 Nov; 217():115808. PubMed ID: 37716622
[TBL] [Abstract] [Full Text] [Related]
17. Combination of runx1 inhibitor and gemcitabine mitigates chemo-resistance in pancreatic ductal adenocarcinoma by modulating BiP/PERK/eIF2α-axis-mediated endoplasmic reticulum stress.
She C; Wu C; Guo W; Xie Y; Li S; Liu W; Xu C; Li H; Cao P; Yang Y; Wang X; Chang A; Feng Y; Hao J
J Exp Clin Cancer Res; 2023 Sep; 42(1):238. PubMed ID: 37697370
[TBL] [Abstract] [Full Text] [Related]
18. A Radiomics-Based Model for Potentially More Accurate Identification of Subtypes of breast cancer Brain Metastases.
Cho S; Joo B; Park M; Ahn SJ; Suh SH; Park YW; Ahn SS; Lee SK
Yonsei Med J; 2023 Sep; 64(9):573-580. PubMed ID: 37634634
[TBL] [Abstract] [Full Text] [Related]
19. No evidence for a genetic causal effect of breast cancer on venous thromboembolism: a mendelian randomization study.
Qin Q; Pan Y; Wang L
J Thromb Thrombolysis; 2024 Jan; 57(1):117-123. PubMed ID: 37615800
[TBL] [Abstract] [Full Text] [Related]
20. Artificial intelligence-supported screen reading versus standard double reading in the Mammography Screening with Artificial Intelligence trial (MASAI): a clinical safety analysis of a randomised, controlled, non-inferiority, single-blinded, screening accuracy study.
Lång K; Josefsson V; Larsson AM; Larsson S; Högberg C; Sartor H; Hofvind S; Andersson I; Rosso A
Lancet Oncol; 2023 Aug; 24(8):936-944. PubMed ID: 37541274
[TBL] [Abstract] [Full Text] [Related]
[Next]
